Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Probability of recurrence of thrombosis in patients with and without factor V Leiden.

Thrombosis and haemostasis - 1 Feb 1996

Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C

Abstract excerpt

Activated protein C (APC) resistance is a common risk factor for venous thromboembolism and is associated with the replacement of Arg 506 by Gln in the factor V gene (factor V Leiden). We investigated the risk of recurrence of venous thromboembolism in APC resistant patients heterozygous for FV L...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Disease Susceptibility
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to APC gene

Share to Genotype

Share to Incidence

Share to Prevalence

Share to Risk Factors

Source

Identifiers

PMID: 8815565

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-8815565-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Probability of recurrence of thrombosis in patients with and without factor V Leiden.PMID 8815565Read ↗

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.Semantic proximity Read ↗

Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.Semantic proximity Read ↗

Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.Semantic proximity Read ↗

Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.Semantic proximity Read ↗

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationSemantic proximity Read ↗

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.Semantic proximity Read ↗

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.Semantic proximity Read ↗

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disordersSemantic proximity Read ↗

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.Semantic proximity Read ↗

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.